Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinjin Capsule is a Traditional Chinese Medicine (TCM) developed and manufactured by Heilongjiang Tianyi Pharmaceutical Co., Ltd. It is primarily indicated for the treatment of acute simple pharyngitis, particularly cases characterized by wind-heat symptoms in TCM theory, such as sore throat, congestion, and localized pain. The formulation consists of several botanical ingredients, including Radix Ilicis Asprellae, Radix Helicteris, Folium Viticis Negundo, Herba Andrographitis, and Herba Taraxaci. These components work synergistically to clear heat, detoxify, and provide anti-inflammatory and analgesic relief to the pharyngeal mucosa. It is administered orally and is widely used in the Chinese market for upper respiratory discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinjin Capsule.